Evidence map›Paper›PMID 32715288›Full record

ArticleKidney medicine

Global Glomerulosclerosis in Kidney Biopsies With Differing Amounts of Cortex: A Clinical-Pathologic Correlation Study.

Robert S Niznik, Camden L Lopez, Walter K Kremers, Aleksandar Denic, Sanjeev Sethi, Mark D Stegall, Joshua J Augustine, Andrew D Rule

Open access · goldAbstract read
In one paragraph

Article in Kidney medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Performing a percutaneous kidney biopsy.World journal of nephrology · 2026
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Robert S NiznikDivisions of Nephrology and Hypertension (RSN, AD) and Biomedical Statistics and Informatics (CLL, WKK), and Departments of Laboratory Medicine and Pathology (SS) and Surgery (MDS), Mayo Clinic, Rochester, MN; Department of Nephrology, Cleveland Clinic, Cleveland, OH (JJA); and Division of Epidemiology, Mayo Clinic, Rochester, MN (ADR).
Camden L LopezDivisions of Nephrology and Hypertension (RSN, AD) and Biomedical Statistics and Informatics (CLL, WKK), and Departments of Laboratory Medicine and Pathology (SS) and Surgery (MDS), Mayo Clinic, Rochester, MN; Department of Nephrology, Cleveland Clinic, Cleveland, OH (JJA); and Division of Epidemiology, Mayo Clinic, Rochester, MN (ADR).
Walter K KremersDivisions of Nephrology and Hypertension (RSN, AD) and Biomedical Statistics and Informatics (CLL, WKK), and Departments of Laboratory Medicine and Pathology (SS) and Surgery (MDS), Mayo Clinic, Rochester, MN; Department of Nephrology, Cleveland Clinic, Cleveland, OH (JJA); and Division of Epidemiology, Mayo Clinic, Rochester, MN (ADR).
Aleksandar DenicDivisions of Nephrology and Hypertension (RSN, AD) and Biomedical Statistics and Informatics (CLL, WKK), and Departments of Laboratory Medicine and Pathology (SS) and Surgery (MDS), Mayo Clinic, Rochester, MN; Department of Nephrology, Cleveland Clinic, Cleveland, OH (JJA); and Division of Epidemiology, Mayo Clinic, Rochester, MN (ADR).
Sanjeev SethiDivisions of Nephrology and Hypertension (RSN, AD) and Biomedical Statistics and Informatics (CLL, WKK), and Departments of Laboratory Medicine and Pathology (SS) and Surgery (MDS), Mayo Clinic, Rochester, MN; Department of Nephrology, Cleveland Clinic, Cleveland, OH (JJA); and Division of Epidemiology, Mayo Clinic, Rochester, MN (ADR).
Mark D StegallDivisions of Nephrology and Hypertension (RSN, AD) and Biomedical Statistics and Informatics (CLL, WKK), and Departments of Laboratory Medicine and Pathology (SS) and Surgery (MDS), Mayo Clinic, Rochester, MN; Department of Nephrology, Cleveland Clinic, Cleveland, OH (JJA); and Division of Epidemiology, Mayo Clinic, Rochester, MN (ADR).
Joshua J AugustineDivisions of Nephrology and Hypertension (RSN, AD) and Biomedical Statistics and Informatics (CLL, WKK), and Departments of Laboratory Medicine and Pathology (SS) and Surgery (MDS), Mayo Clinic, Rochester, MN; Department of Nephrology, Cleveland Clinic, Cleveland, OH (JJA); and Division of Epidemiology, Mayo Clinic, Rochester, MN (ADR).
Andrew D RuleDivisions of Nephrology and Hypertension (RSN, AD) and Biomedical Statistics and Informatics (CLL, WKK), and Departments of Laboratory Medicine and Pathology (SS) and Surgery (MDS), Mayo Clinic, Rochester, MN; Department of Nephrology, Cleveland Clinic, Cleveland, OH (JJA); and Division of Epidemiology, Mayo Clinic, Rochester, MN (ADR).
Mayo Clinic · USMayo Clinic in Arizona · USCleveland Clinic · US

Funding

The macro- and micro- anatomy and pathology of the aging kidneyR01DK090358 · NIDDK · MAYO CLINIC ROCHESTER · PI ANDREW David RULE · 2011 to 2026
$9.9M
NIDDK NIH HHS R01 DK090358
6 · The paper itself

Abstract

RATIONALE &

objectiveThe number of glomeruli is often used to determine the adequacy of a kidney biopsy (eg, at least 10 glomeruli). It is often assumed that biopsy specimens with limited amounts of cortex are too imprecise for detection of focal pathology. STUDY

designClinical-pathologic correlation (cross-sectional). SETTING &

participantsLiving kidney donors who underwent a needle core biopsy of their kidney at the time of donation. EXPOSURE: The amount of cortex biopsied as determined by either the number of glomeruli or area of cortex on histology. OUTCOME: The percentage of globally sclerotic glomeruli, density of interstitial fibrosis foci, and severity of arteriosclerosis were determined. ANALYTICAL APPROACH: A beta-binomial model assessed how the mean percentage of globally sclerotic glomeruli and patient variability in percentage of globally sclerotic glomeruli differed with the number of glomeruli on the biopsy specimen. Additional models assessed the association of interstitial fibrosis and arteriosclerosis with number of glomeruli.

resultsThere were 2,915 kidney donors studied. Fewer glomeruli on the biopsy specimen associated with higher mean percentage of globally sclerotic glomeruli and higher patient variability in percentage of globally sclerotic glomeruli. Smaller cortical volume on imaging correlated with both less cortex on biopsy and higher percentage of globally sclerotic glomeruli. Based on a statistical simulation, the probability of patient percentage of globally sclerotic glomeruli ≥ 10% if the biopsy percentage of globally sclerotic glomeruli is ≥10% (positive predictive value) was 45% with 1 to 9 glomeruli versus 31% with 10 or more glomeruli; the negative predictive value was 91% versus 98%. Fewer glomeruli also associated with more interstitial fibrosis and arteriosclerosis. LIMITATIONS: The study was limited to living kidney donors. Patient variability in percentage of globally sclerotic glomeruli was based on a statistical model because multiple biopsy specimens per patient were not available.

conclusionsThe amount of cortex on a needle core biopsy is not completely random. Chronic changes from loss of cortex contribute to low amounts of cortex on a kidney biopsy specimen.

Identifiers

PMID32715288
PMCPMC7380371
OpenAlexW2958545213

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.